IMV Inc IMVIF

RE:RE:RE:RE:Imv Presents New Positive Data From Phase 1b/2

[PoorOpinion]

alphaseeking001 wrote: Yes, drug resitance is a commonality for essentially ALL cancers for all therapies so far.  One of the primary reasons why they are such a bi%$ to treat.  I'm not shocked that they are finding out some mechanisms that some of the tumors are getting around IMV's treatment... they get around ALL cancer therapies.  The key here and I agree with you is that these are very good results indeed and will definitly spark further interest in our technology!  Remember... these are the ovarian cancers that have already survived and beaten every other therapy thrown at them...!  The fact that we are getting results like these in THIS cohort, I feel are very good!  Love to here even more feedback from those posters that have more of an immunology background than I do.  I may be in the medical field but immunology is not a prime part of my practice.  

I had a friend that spent 10 years jumping from treatment to treatment, having drugs control her condition and then have them fail as her cancer adapted. Just like this population the cancers will have developed a variety of survival mechanisms, some of them making them already resistant to IMV's drug, its prrfectly normal. Presumably if this drug continues in development and they get deeper into the MOA they can possibly develop a companion diagnostic that identifies the most(and least) suseptible.